Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TARS
#1600
Tarsus Pharmaceuticals, Inc. - Common Stock
74.4
0
USD
+0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+1.69%
Monthly Change
-6.64%
6 month change
+2.38%
Year Change
+12.62%
Previous Close
73.1
6
Open
73.2
0
Low
72.9
8
High
76.6
3
Markets
US Stock Market
Healthcare
Biotechnology
TARS
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
20.5 M
20.71 M
26.73 M
34.22 M
38.38 M
42.56 M
43.88 M
Valuation ratios
Enterprise value
679.26 M
294.62 M
333.24 M
494.72 M
2.1 B
3.37 B
3.13 B
Price to earnings ratio
—
-33.58
-5.72
-4.36
-18.04
-51.5
-70.06
Price to sales ratio
—
8.11
13.75
33.95
11.38
7.58
5.23
Price to cash flow ratio
—
123.39
-7.24
-5.04
-25.08
-274.78
42.97
Price to book ratio
—
2.77
1.84
3.01
9.27
9.96
2.31
Enterprise value to EBITDA ratio
-25.34
-25.52
-5.28
-3.41
-17.08
-45.56
-63.9
Profitability ratios
Return on assets %
-0.16
-0.08
-0.27
-0.51
-0.31
-0.12
-0.03
Return on equity %
-0.16
-0.08
-0.32
-0.69
-0.51
-0.19
-0.05
Return on invested capital %
-1 906.71
-561.75
-2 112.36
-2 838.11
-1 840.82
-414.63
-106.18
Gross margin %
—
100
100
100
100
100
93.03
Operating margin %
—
-21.32
-242.92
-820.53
-65.9
-15.72
-11.45
EBITDA margin %
—
-20.24
-244.4
-831.43
-67.27
-16.4
-11.21
Net margin %
—
-24.25
-240.51
-778.89
-63.16
-14.72
-10.67
Liquidity ratios
Quick ratio
—
—
—
6.85
4.39
3.82
3.17
Current ratio
31.68
15.33
14.61
6.93
4.42
3.85
3.2
Inventory turnover
—
—
—
—
—
—
2.71
Asset turnover
0
0.33
0.13
0.07
0.57
0.8
0.29
Solvency ratios
Debt to assets ratio
—
—
0.09
0.11
0.19
0.13
0.12
Debt to equity ratio
—
—
0.1
0.15
0.32
0.21
0.21
Long term debt to total assets ratio
—
—
0.09
0.11
0.19
0.13
0.12
Long term debt to total equity ratio
—
—
0.1
0.15
0.32
0.21
0.21
Per share metrics
Operating cash flow per share
—
0.18
-1.99
-4
-2.21
-0.3
1.73
EBIT per share
—
-0.59
-2.55
-4.87
-3.21
-1.7
-1.13
EBITDA per share
—
-0.56
-2.56
-4.94
-3.27
-1.77
-1.14
Total debt per share
—
—
0.79
1.01
1.91
1.73
1.68
Cash per share
—
8.36
8.82
7.74
7.75
9.99
10.36
Net current asset value per share
—
8.56
9.15
8.72
9.49
12.51
12.95
Tangible book value per share
—
8.11
7.84
6.7
5.97
8.04
7.83
Working capital per share
—
8
8.53
7.46
7.34
9.26
8.9
Book value per share
—
8.11
7.84
6.7
5.97
8.22
7.99
News
Tarsus Stock: XDEMVY Now Pays The Bills, And The Retina Deals Work Like Options (TARS)
AI Computer Giant Super Micro Heads Group Of 15 Standouts New To Best Stocks Lists
AI Flash Memory Maker Everpure Among 16 Growth Names On IBD Best Stock Lists
Goldman Sachs Reinstates Buy on Tarsus Pharmaceuticals, Announces $116 Price Target
Nvidia Among Surging Chipmakers, Leads 21 To Best Stock Lists
When To Dump Stocks: These IBD 50 Components Hit Sell Signals
Lumentum, WisdomTree, Incyte Among 15 Stocks Popping Up On IBD's Roving Watchlists
Agnico Eagle Mines, Charles Schwab, 16 Other Stocks Added To IBD Watchlists
AI Giant Micron, Gold Miners Among 18 Names Landing On Best Stock Screens
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q2 Loss, Tops Revenue Estimates
Agenus (AGEN) Earnings Expected to Grow: Should You Buy?
Tarsus Pharmaceuticals, Inc. (TARS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release